Scotland · NHS Scotland MSAN
Oral Contraceptive tablets (various brands)
MSAN(2020)98 · Level 2 · issued 09 Oct 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Brevinor® 35microgram/500 microgram January norethisterone OCP products remain available. | Available | — |
| products remain available. | Available | — |
| 35microgram/1mg tablets 2021 remain available. | Available | — |
| 35microgram/1mg tablets differing composition remain available (see table | Available | — |
| Yiznell® Ethinylestradiol/drospirenone November remain available from suppliers of following brands: | Available | — |
| health professionals on the use of combined hormonal contraceptives is available from | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2020:98
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
278d7de9b8fa6cc3bc31ea9e1426d74e77096e422f94b8da5497e281c0cbfc95sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2020-98.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.